LONDON (Reuters) - GlaxoSmithKline is holding talks this weekend with Human Genome Sciences to agree a deal to acquire it for some $2.6 billion, after pursuing the U.S. biotech firm for three months, sources familiar with the situation said on Sunday.
via Reuters: Health News Read More Here..
No comments:
Post a Comment